Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism

被引：0
作者：
Tim K Mackey
Bryan A Liang
机构：
[1] University of California,Department of Anesthesiology
[2] San Diego School of Medicine,San Diego Center for Patient Safety
[3] University of California San Diego School of Medicine,Institute of Health Law Studies
[4] California Western School of Law,undefined
来源：
BMC Medicine | / 11卷
关键词：
Counterfeit medicines; Global health governance; Global health policy; Drug supply chain; Falsified medicines; Fraudulent medicines; Substandard medicines;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 37 条
[1]  
Attaran A(2012)How to achieve international action on falsified and substandard medicines BMJ 345 e7381-4579
[2]  
Barry D(2011)The global counterfeit drug trade: patient safety and public health risks J Pharm Sci 100 4571-1694
[3]  
Basheer S(2013)Stemming the global trade in falsified and substandard MedicinesStemming the global trade in substandard medicines JAMA 309 1693-449
[4]  
Bate R(2007)Tackling corruption in the pharmaceutical systems worldwide with courage and conviction Clin Pharmacol Ther 81 445-184
[5]  
Benton D(2009)Searching for safety: addressing search engine, website, and provider accountability for illicit online drug sales Am J Law Med 35 125-2951
[6]  
Chauvin J(2012)Internet-ordered Viagra (sildenafil citrate) is rarely genuine J Sex Med 9 2943-108
[7]  
Garrett L(2012)Vaccine shortages and suspect online pharmacy sellers Vaccine 30 105-146
[8]  
Kickbusch I(2003)Availability of opioids on the internet JAMA 290 889-343
[9]  
Kohler JC(2006)The marketing of opioid medications without prescription over the internet J Publ Pol Market 25 133-15
[10]  
Midha K(2012)Oncology and the internet: regulatory failure and reform J Oncol Pract 8 341-undefined
1234